Dermatitis Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Dermatitis stocks.

Dermatitis Stocks Recent News

Date Stock Title
May 8 REGN Regeneron gene therapy improves hearing in child deafness
May 8 KYMR Kymera Therapeutics to Participate in Upcoming May Investor Conferences
May 8 REGN Latest DB-OTO Results Show Dramatically Improved Hearing to Normal Levels in a Child with Profound Genetic Deafness within 24 Weeks and Initial Hearing Improvements in a Second Child at 6 Weeks
May 7 BHC Why Bausch Health Stock Plunged After Posting First Quarter 2024 Results
May 6 REGN Regeneron Announces Investor Conference Presentations
May 6 REGN Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks
May 6 APGE Apogee Therapeutics to Participate at the 2024 Bank of America Healthcare Conference
May 6 VYNE VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET Inhibitor
May 6 BHC Bausch Health Companies (NYSE:BHC investor three-year losses grow to 72% as the stock sheds US$388m this past week
May 5 KYMR Kymera Therapeutics, Inc. (NASDAQ:KYMR) Just Released Its First-Quarter Earnings: Here's What Analysts Think
May 5 REGN Wall Street Breakfast: The Week Ahead
May 4 REGN 23 Most Profitable Stocks of the Last 12 Months
May 3 BHC Bausch + Lomb Corporation (NYSE:BLCO) Q1 2024 Earnings Call Transcript
May 3 BHC Bausch Health Companies Inc. (NYSE:BHC) Q1 2024 Earnings Call Transcript
May 3 KYMR Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q1 2024 Earnings Call Transcript
May 3 REGN Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q1 2024 Earnings Call Transcript
May 3 KYMR Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
May 3 KYMR Wall Street Analysts Predict a 34.41% Upside in Kymera Therapeutics (KYMR): Here's What You Should Know
May 3 BHC Bausch (BHC) Q1 Earnings and Revenues Miss, Shares Fall
May 3 REGN Regeneron Pharmaceuticals First Quarter 2024 Earnings: Misses Expectations
Dermatitis

Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These diseases are characterized by itchiness, red skin and a rash. In cases of short duration, there may be small blisters, while in long-term cases the skin may become thickened. The area of skin involved can vary from small to the entire body.Dermatitis is a group of skin conditions that includes atopic dermatitis, allergic contact dermatitis, irritant contact dermatitis and stasis dermatitis. The exact cause of dermatitis is often unclear. Cases may involve a combination of irritation, allergy and poor venous return. The type of dermatitis is generally determined by the person's history and the location of the rash. For example, irritant dermatitis often occurs on the hands of people who frequently get them wet. Allergic contact dermatitis occurs upon exposure to an allergen, causing a hypersensitivity reaction in the skin.Treatment of atopic dermatitis is typically with moisturizers and steroid creams. The steroid creams should generally be of mid- to high strength and used for less than two weeks at a time as side effects can occur. Antibiotics may be required if there are signs of skin infection. Contact dermatitis is typically treated by avoiding the allergen or irritant. Antihistamines may help with sleep and to decrease nighttime scratching.Dermatitis was estimated to affect 245 million people globally in 2015. Atopic dermatitis is the most common type and generally starts in childhood. In the United States, it affects about 10–30% of people. Contact dermatitis is twice as common in females than males. Allergic contact dermatitis affects about 7% of people at some point in time. Irritant contact dermatitis is common, especially among people who do certain jobs; exact rates are unclear.

Browse All Tags